Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether Coagadex is available on the NHS for patients with the hereditary factor X deficiency bleeding disorder; and if he will make a statement.

At present, NHS England does not routinely commission Coagadex for any indication.

A commissioning policy proposal for the prescribing of Coagedex for patients with the hereditary factor X deficiency bleeding disorder has been developed. The Clinical Priorities Advisory Group (CPAG) makes recommendations on NHS England's approach to commissioning services, treatments and technologies, and considers which of these should be prioritised for investment. The CPAG will make its recommendations regarding the commissioning of Coagadex to NHS England in May 2018.